[Recommendations] Restructuring Diagnostic Services and Achieving the Necessary Innovation to Promote AMR Control (May 26, 2023)
date : 5/26/2023
Tags: AMR
AMR Alliance Japan (Secretariat: Health and Global Policy Institute) aims to promote antimicrobial resistance (AMR) measures, and have published a proposal on the reconstruction of the testing system that contributes to the diagnosis of antimicrobial resistant organism and the innovation required for that purpose.
In recent years, the G7 has recognized that achieving comprehensive innovation in all areas of prevention, diagnosis, and treatment will be crucial for pandemic prevention, preparedness, and response (PPR). AMR Alliance Japan has worked to make the most of this momentum and has already presented recommendations focusing on treatment and pull incentives.
In response to the structural issues facing the testing market, there is a growing international need for restructuring testing systems and innovation, which was discussed at the 152nd World Health Organization Executive Council meeting in January-February 2023. Therefore, looking beyond the 2023 G7 Hiroshima Summit, we will publish recommendations specific to tests that contribute to diagnostic support, which are necessary to promote comprehensive and effective AMR countermeasures.
The outline of the recommendations is as follows.
Recommendation 1: Reaffirm that testing plays a vital role in diagnostic support and restructure diagnostic services to advance AMR countermeasures that are also compatible with a super-aging society.
Recommendation 2: Develop human resources and foster an environment to enable proactive AMR screening, microorganism identification, and drug susceptibility testing (including genetic testing).
Recommendation 3: While taking conditions at healthcare institutions and in each region into account, consider new incentives to expand diagnostic services at healthcare institutions by promoting testing systems that can be implemented in-house or that will improve the positions of and profitability for in-house and external testing departments.
The details can be found below.
Top Research & Recommendations Posts
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Announcement] HGPI Planetary Health Policy Team Joins Call for Global Fossil Fuel Non-proliferation Treaty (October 18, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-03-04
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Issues Surrounding and Necessary Measures Against Obesity Disease” (February 2, 2024)
-
2024-03-05
[HGPI Policy Column] (No.41) – From the Mental Health Project Team – Mental Health Policy in Japan – History and Future Policy Topics (Part 1 of HGPI Activities for Mental Health and Domestic Policy History)
-
2024-03-18
[Registration Open] International Symposium “Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (April 9, 2024)
-
2024-03-22
[Registration Open] (Hybrid Format) The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Global Expert Meeting: Toward Equitable Patient Access to Genomic Cancer Medicine (April 4, 2024)
-
2024-03-26
[Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)